Sudeep Pharma credit ratios

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026

	148	148
	33.6	33.6
	0.17×	0.17×
	0.04×	0.04×
	0.67×	0.67×
	0.13×	0.15×
	27.23×	27.23×
	13.2%	14.2%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

SUDEEPPHRM₹1,130.10

Sudeep Pharma Ltd.

· Chemicals

₹ CrorePeersSUDARSCHEM STYRENIX SHARDACROP REFEX RCF RALLIS RAIN PRIVISCLMcap ₹12,764 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY26 31/03/2026	Last 12M 30/09/2026
Total Debt	148.3	148.3
Net Debt	33.6	33.6
Total Debt/Equity	0.17	0.17
Net Debt/Equity	0.04	0.04
Total Debt/EBITDA	0.67	0.67
Net Debt/EBITDA	0.15	0.13
Interest Coverage (EBIT/Interest)	27.23	27.23
Total Debt/Total Capital %	14.17	13.23

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.